With war-related trauma in ample supply, Israel-based GrayMatters Health presses on with the goal of healing PTSD.
The sizable raise for Genesis comes as the generative AI space race heats up in biomedicine.
Nearly six years after fraud allegations stained Outcome Health’s reputation, its former CEO and two other top executives have been convicted.
The telehealth firm is slashing 20% of staff, a move designed to match patient demand and lower growth targets.
As the second installment of this series shows, AI and machine learning in healthcare are heading in some fascinating directions.
As the first installment of this two-part series shows, the future of AI and machine learning in healthcare doesn’t belong to any single vendor.
Conrad joined the company this month and is based in its San Francisco headquarters.
Nanobiosym hired the agency shortly after its proprietary technology was approved by the FDA.
Thanks to legalization, a new breed of startups are changing the nature of cannabis advertising.
MM&M has announced its annual showcase of executives, investors, entrepreneurs, designers and thinkers who are ushering the industry into its new technological golden era.
MM+M Transform: The Patient, Provider and Payer Engagement Matrix provides the most in-depth look at the marketing and technology trends likely to influence the industry’s growth over the next year.
Get the most out of
Register for free and enjoy unlimited access to: